Backloading Deal Value for Profitability in Biotech Deals?
Executive SummaryUpfront payments for approved products far exceed those in earlier-stage deals, as biotechs have the leverage to demand higher upfronts--but should they demand high upfronts, if reaching profitability is the goal?
You may also be interested in...
The December 12 UK general election returned a Conservative majority, the scale or which few would have predicted. It means that the new government can press on with its plans for Brexit, the uncertainty now surrounding only when, not if.